ExodusPoint Capital Management, LP - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 103 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2022$29,000
-90.8%
10,077
-90.3%
0.00%
-100.0%
Q4 2021$316,000
-60.6%
103,955
-9.2%
0.00%
-72.7%
Q3 2021$803,000
+117.0%
114,517
+183.9%
0.01%
+175.0%
Q2 2021$370,000
-35.4%
40,331
-31.6%
0.00%
-50.0%
Q1 2021$573,000
+83.1%
58,950
+93.3%
0.01%
+166.7%
Q4 2020$313,000
-18.7%
30,501
-20.0%
0.00%
-62.5%
Q3 2020$385,000
+14.6%
38,142
+18.2%
0.01%
-11.1%
Q2 2020$336,000
-5.6%
32,257
-2.4%
0.01%
-25.0%
Q3 2019$356,00033,0570.01%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
HARVARD MANAGEMENT CO INC 600,000$45,216,0003.56%
Avalon Global Asset Management LLC 32,900$2,479,0001.79%
CORNERSTONE CAPITAL MANAGEMENT LLC 495,145$37,314,0001.58%
BB BIOTECH AG 521,991$39,337,0001.25%
WEATHERBIE CAPITAL, LLC 137,041$10,327,0001.20%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$428,527,0001.19%
TOBAM 318,384$23,994,0000.94%
Orbimed Advisors 1,195,500$90,093,0000.91%
Capital International Sarl 109,405$8,245,0000.74%
CAPITAL INTERNATIONAL LTD /CA/ 145,697$10,980,0000.73%
View complete list of PUMA BIOTECHNOLOGY INC shareholders